nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifabutin—Burkitt's lymphoma—Methotrexate—colon cancer	0.0379	0.11	CcSEcCtD
Rifabutin—HSP90B1—gall bladder—colon cancer	0.0297	0.0908	CbGeAlD
Rifabutin—HSP90AA1—endothelium—colon cancer	0.025	0.0765	CbGeAlD
Rifabutin—HSP90AA1—blood vessel—colon cancer	0.0231	0.0706	CbGeAlD
Rifabutin—HSP90AA1—gall bladder—colon cancer	0.0217	0.0664	CbGeAlD
Rifabutin—HSP90B1—embryo—colon cancer	0.0188	0.0576	CbGeAlD
Rifabutin—HSP90B1—epithelium—colon cancer	0.0154	0.047	CbGeAlD
Rifabutin—HSP90B1—smooth muscle tissue—colon cancer	0.0148	0.0453	CbGeAlD
Rifabutin—HSP90B1—renal system—colon cancer	0.0143	0.0436	CbGeAlD
Rifabutin—White blood cell disorder—Capecitabine—colon cancer	0.0141	0.0409	CcSEcCtD
Rifabutin—HSP90AA1—embryo—colon cancer	0.0138	0.0421	CbGeAlD
Rifabutin—HSP90B1—lymphoid tissue—colon cancer	0.0118	0.0362	CbGeAlD
Rifabutin—HSP90B1—digestive system—colon cancer	0.0117	0.0357	CbGeAlD
Rifabutin—HSP90AA1—epithelium—colon cancer	0.0112	0.0344	CbGeAlD
Rifabutin—HSP90AA1—smooth muscle tissue—colon cancer	0.0108	0.0331	CbGeAlD
Rifabutin—HSP90B1—bone marrow—colon cancer	0.0108	0.0329	CbGeAlD
Rifabutin—HSP90AA1—renal system—colon cancer	0.0104	0.0319	CbGeAlD
Rifabutin—Urine color abnormal—Capecitabine—colon cancer	0.0103	0.0301	CcSEcCtD
Rifabutin—HSP90B1—vagina—colon cancer	0.0103	0.0316	CbGeAlD
Rifabutin—Developmental delay—Fluorouracil—colon cancer	0.00918	0.0267	CcSEcCtD
Rifabutin—Congenital anomaly—Fluorouracil—colon cancer	0.00918	0.0267	CcSEcCtD
Rifabutin—HSP90B1—liver—colon cancer	0.00871	0.0266	CbGeAlD
Rifabutin—HSP90AA1—lymphoid tissue—colon cancer	0.00865	0.0265	CbGeAlD
Rifabutin—HSP90AA1—digestive system—colon cancer	0.00855	0.0261	CbGeAlD
Rifabutin—Emotional distress—Fluorouracil—colon cancer	0.00821	0.0239	CcSEcCtD
Rifabutin—HSP90AA1—bone marrow—colon cancer	0.00788	0.0241	CbGeAlD
Rifabutin—HSP90AA1—vagina—colon cancer	0.00755	0.0231	CbGeAlD
Rifabutin—Lymphopenia—Irinotecan—colon cancer	0.00712	0.0207	CcSEcCtD
Rifabutin—Chromaturia—Capecitabine—colon cancer	0.00683	0.0199	CcSEcCtD
Rifabutin—HSP90B1—lymph node—colon cancer	0.00668	0.0204	CbGeAlD
Rifabutin—Congenital anomaly—Capecitabine—colon cancer	0.00641	0.0187	CcSEcCtD
Rifabutin—Developmental delay—Capecitabine—colon cancer	0.00641	0.0187	CcSEcCtD
Rifabutin—HSP90AA1—liver—colon cancer	0.00637	0.0195	CbGeAlD
Rifabutin—Gastrointestinal symptom NOS—Fluorouracil—colon cancer	0.00593	0.0173	CcSEcCtD
Rifabutin—HSP90AA1—lymph node—colon cancer	0.00488	0.0149	CbGeAlD
Rifabutin—Lymphopenia—Capecitabine—colon cancer	0.00477	0.0139	CcSEcCtD
Rifabutin—Platelet count decreased—Capecitabine—colon cancer	0.0041	0.0119	CcSEcCtD
Rifabutin—Bacterial infection—Methotrexate—colon cancer	0.00393	0.0115	CcSEcCtD
Rifabutin—Blood bilirubin increased—Irinotecan—colon cancer	0.00385	0.0112	CcSEcCtD
Rifabutin—Aphasia—Capecitabine—colon cancer	0.00376	0.0109	CcSEcCtD
Rifabutin—Phosphatase alkaline increased—Irinotecan—colon cancer	0.00364	0.0106	CcSEcCtD
Rifabutin—CYP1A2—renal system—colon cancer	0.00337	0.0103	CbGeAlD
Rifabutin—Blood alkaline phosphatase increased—Irinotecan—colon cancer	0.00304	0.00886	CcSEcCtD
Rifabutin—Aphasia—Methotrexate—colon cancer	0.0028	0.00815	CcSEcCtD
Rifabutin—CYP1A2—digestive system—colon cancer	0.00276	0.00845	CbGeAlD
Rifabutin—Chest discomfort—Capecitabine—colon cancer	0.00276	0.00803	CcSEcCtD
Rifabutin—Skin discolouration—Capecitabine—colon cancer	0.0027	0.00786	CcSEcCtD
Rifabutin—Blood bilirubin increased—Capecitabine—colon cancer	0.00258	0.00751	CcSEcCtD
Rifabutin—Aspartate aminotransferase increased—Vincristine—colon cancer	0.00245	0.00712	CcSEcCtD
Rifabutin—CYP3A4—renal system—colon cancer	0.00244	0.00746	CbGeAlD
Rifabutin—Phosphatase alkaline increased—Capecitabine—colon cancer	0.00244	0.0071	CcSEcCtD
Rifabutin—Aspartate aminotransferase increased—Irinotecan—colon cancer	0.00238	0.00694	CcSEcCtD
Rifabutin—Pancytopenia—Vincristine—colon cancer	0.00223	0.00649	CcSEcCtD
Rifabutin—Neutropenia—Vincristine—colon cancer	0.00219	0.00639	CcSEcCtD
Rifabutin—Eosinophilia—Fluorouracil—colon cancer	0.00217	0.00631	CcSEcCtD
Rifabutin—Neutropenia—Irinotecan—colon cancer	0.00214	0.00623	CcSEcCtD
Rifabutin—Pancytopenia—Fluorouracil—colon cancer	0.00208	0.00606	CcSEcCtD
Rifabutin—CYP1A2—liver—colon cancer	0.00206	0.00629	CbGeAlD
Rifabutin—Blood alkaline phosphatase increased—Capecitabine—colon cancer	0.00204	0.00593	CcSEcCtD
Rifabutin—Skin discolouration—Methotrexate—colon cancer	0.00201	0.00585	CcSEcCtD
Rifabutin—CYP3A4—digestive system—colon cancer	0.002	0.00612	CbGeAlD
Rifabutin—Jaundice—Irinotecan—colon cancer	0.00199	0.00579	CcSEcCtD
Rifabutin—Hepatic enzyme increased—Methotrexate—colon cancer	0.00192	0.00559	CcSEcCtD
Rifabutin—Connective tissue disorder—Vincristine—colon cancer	0.00185	0.00538	CcSEcCtD
Rifabutin—Agranulocytosis—Fluorouracil—colon cancer	0.00182	0.00531	CcSEcCtD
Rifabutin—Connective tissue disorder—Irinotecan—colon cancer	0.0018	0.00524	CcSEcCtD
Rifabutin—Immune system disorder—Irinotecan—colon cancer	0.00165	0.00481	CcSEcCtD
Rifabutin—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.00159	0.00464	CcSEcCtD
Rifabutin—Flatulence—Irinotecan—colon cancer	0.00157	0.00457	CcSEcCtD
Rifabutin—Alanine aminotransferase increased—Capecitabine—colon cancer	0.00156	0.00455	CcSEcCtD
Rifabutin—Anaemia—Vincristine—colon cancer	0.00151	0.0044	CcSEcCtD
Rifabutin—Bronchospasm—Capecitabine—colon cancer	0.0015	0.00438	CcSEcCtD
Rifabutin—CYP3A4—liver—colon cancer	0.00149	0.00456	CbGeAlD
Rifabutin—Anaemia—Irinotecan—colon cancer	0.00147	0.00429	CcSEcCtD
Rifabutin—Leukopenia—Vincristine—colon cancer	0.00146	0.00426	CcSEcCtD
Rifabutin—Pancytopenia—Capecitabine—colon cancer	0.00145	0.00423	CcSEcCtD
Rifabutin—Neutropenia—Capecitabine—colon cancer	0.00143	0.00417	CcSEcCtD
Rifabutin—Leukopenia—Irinotecan—colon cancer	0.00143	0.00415	CcSEcCtD
Rifabutin—Convulsion—Vincristine—colon cancer	0.00142	0.00413	CcSEcCtD
Rifabutin—Anaemia—Fluorouracil—colon cancer	0.00141	0.00411	CcSEcCtD
Rifabutin—Myalgia—Vincristine—colon cancer	0.00139	0.00405	CcSEcCtD
Rifabutin—Leukopenia—Fluorouracil—colon cancer	0.00137	0.00398	CcSEcCtD
Rifabutin—Jaundice—Capecitabine—colon cancer	0.00133	0.00387	CcSEcCtD
Rifabutin—Convulsion—Fluorouracil—colon cancer	0.00132	0.00385	CcSEcCtD
Rifabutin—Confusional state—Irinotecan—colon cancer	0.00131	0.00382	CcSEcCtD
Rifabutin—Thrombocytopenia—Vincristine—colon cancer	0.00131	0.00381	CcSEcCtD
Rifabutin—Chest pain—Fluorouracil—colon cancer	0.0013	0.00378	CcSEcCtD
Rifabutin—Myalgia—Fluorouracil—colon cancer	0.0013	0.00378	CcSEcCtD
Rifabutin—Hepatobiliary disease—Capecitabine—colon cancer	0.00129	0.00376	CcSEcCtD
Rifabutin—Shock—Irinotecan—colon cancer	0.00128	0.00372	CcSEcCtD
Rifabutin—Agranulocytosis—Capecitabine—colon cancer	0.00127	0.00371	CcSEcCtD
Rifabutin—Thrombocytopenia—Irinotecan—colon cancer	0.00127	0.00371	CcSEcCtD
Rifabutin—Anorexia—Vincristine—colon cancer	0.00127	0.00371	CcSEcCtD
Rifabutin—Confusional state—Fluorouracil—colon cancer	0.00126	0.00366	CcSEcCtD
Rifabutin—Anorexia—Irinotecan—colon cancer	0.00124	0.00361	CcSEcCtD
Rifabutin—Hepatitis—Capecitabine—colon cancer	0.00122	0.00357	CcSEcCtD
Rifabutin—Thrombocytopenia—Fluorouracil—colon cancer	0.00122	0.00355	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Vincristine—colon cancer	0.00122	0.00354	CcSEcCtD
Rifabutin—Insomnia—Vincristine—colon cancer	0.00121	0.00352	CcSEcCtD
Rifabutin—Connective tissue disorder—Capecitabine—colon cancer	0.0012	0.0035	CcSEcCtD
Rifabutin—Paraesthesia—Vincristine—colon cancer	0.0012	0.00349	CcSEcCtD
Rifabutin—Anorexia—Fluorouracil—colon cancer	0.00119	0.00346	CcSEcCtD
Rifabutin—Insomnia—Irinotecan—colon cancer	0.00118	0.00342	CcSEcCtD
Rifabutin—Paraesthesia—Irinotecan—colon cancer	0.00117	0.0034	CcSEcCtD
Rifabutin—Decreased appetite—Vincristine—colon cancer	0.00116	0.00338	CcSEcCtD
Rifabutin—Dyspnoea—Irinotecan—colon cancer	0.00116	0.00338	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Vincristine—colon cancer	0.00115	0.00336	CcSEcCtD
Rifabutin—Eye disorder—Capecitabine—colon cancer	0.00114	0.00333	CcSEcCtD
Rifabutin—Dyspepsia—Irinotecan—colon cancer	0.00114	0.00333	CcSEcCtD
Rifabutin—Pain—Vincristine—colon cancer	0.00114	0.00332	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00113	0.0033	CcSEcCtD
Rifabutin—Decreased appetite—Irinotecan—colon cancer	0.00113	0.00329	CcSEcCtD
Rifabutin—Eosinophilia—Methotrexate—colon cancer	0.00113	0.00328	CcSEcCtD
Rifabutin—Insomnia—Fluorouracil—colon cancer	0.00113	0.00328	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Irinotecan—colon cancer	0.00112	0.00327	CcSEcCtD
Rifabutin—Paraesthesia—Fluorouracil—colon cancer	0.00112	0.00326	CcSEcCtD
Rifabutin—Pain—Irinotecan—colon cancer	0.00111	0.00324	CcSEcCtD
Rifabutin—Dyspnoea—Fluorouracil—colon cancer	0.00111	0.00323	CcSEcCtD
Rifabutin—Immune system disorder—Capecitabine—colon cancer	0.00111	0.00322	CcSEcCtD
Rifabutin—Dyspepsia—Fluorouracil—colon cancer	0.0011	0.00319	CcSEcCtD
Rifabutin—Gastrointestinal pain—Vincristine—colon cancer	0.00109	0.00318	CcSEcCtD
Rifabutin—Decreased appetite—Fluorouracil—colon cancer	0.00108	0.00315	CcSEcCtD
Rifabutin—Pancytopenia—Methotrexate—colon cancer	0.00108	0.00315	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00107	0.00313	CcSEcCtD
Rifabutin—Feeling abnormal—Irinotecan—colon cancer	0.00107	0.00312	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by ERBB2—FGFR3—colon cancer	0.00107	0.00323	CbGpPWpGaD
Rifabutin—Neutropenia—Methotrexate—colon cancer	0.00106	0.0031	CcSEcCtD
Rifabutin—HSP90AA1—Developmental Biology—DCC—colon cancer	0.00106	0.00323	CbGpPWpGaD
Rifabutin—Pain—Fluorouracil—colon cancer	0.00106	0.0031	CcSEcCtD
Rifabutin—Gastrointestinal pain—Irinotecan—colon cancer	0.00106	0.0031	CcSEcCtD
Rifabutin—HSP90AA1—Regulation of Telomerase—EGFR—colon cancer	0.00106	0.00322	CbGpPWpGaD
Rifabutin—Abdominal pain—Vincristine—colon cancer	0.00106	0.00307	CcSEcCtD
Rifabutin—Body temperature increased—Vincristine—colon cancer	0.00106	0.00307	CcSEcCtD
Rifabutin—HSP90AA1—Fcgamma receptor (FCGR) dependent phagocytosis—SRC—colon cancer	0.00105	0.00319	CbGpPWpGaD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—CTNNB1—colon cancer	0.00105	0.00319	CbGpPWpGaD
Rifabutin—Flatulence—Capecitabine—colon cancer	0.00105	0.00306	CcSEcCtD
Rifabutin—HSP90AA1—Integrin-linked kinase signaling—AKT1—colon cancer	0.00105	0.00317	CbGpPWpGaD
Rifabutin—Dysgeusia—Capecitabine—colon cancer	0.00104	0.00304	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—BCL2L1—colon cancer	0.00104	0.00315	CbGpPWpGaD
Rifabutin—Body temperature increased—Irinotecan—colon cancer	0.00103	0.00299	CcSEcCtD
Rifabutin—Abdominal pain—Irinotecan—colon cancer	0.00103	0.00299	CcSEcCtD
Rifabutin—Feeling abnormal—Fluorouracil—colon cancer	0.00103	0.00299	CcSEcCtD
Rifabutin—CYP1A2—Metapathway biotransformation—CHST5—colon cancer	0.00102	0.0031	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—LGR5—colon cancer	0.00101	0.00305	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CHST5—colon cancer	0.00101	0.00305	CbGpPWpGaD
Rifabutin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.001	0.00304	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—FGFR3—colon cancer	0.000993	0.00301	CbGpPWpGaD
Rifabutin—Anaemia—Capecitabine—colon cancer	0.000985	0.00287	CcSEcCtD
Rifabutin—Body temperature increased—Fluorouracil—colon cancer	0.000984	0.00287	CcSEcCtD
Rifabutin—Hypersensitivity—Vincristine—colon cancer	0.000983	0.00286	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—FGFR3—colon cancer	0.00098	0.00297	CbGpPWpGaD
Rifabutin—HSP90AA1—Integrins in angiogenesis—PIK3CA—colon cancer	0.000978	0.00297	CbGpPWpGaD
Rifabutin—HSP90AA1—Validated targets of C-MYC transcriptional activation—MYC—colon cancer	0.000961	0.00292	CbGpPWpGaD
Rifabutin—Hepatobiliary disease—Methotrexate—colon cancer	0.00096	0.0028	CcSEcCtD
Rifabutin—Hypersensitivity—Irinotecan—colon cancer	0.000958	0.00279	CcSEcCtD
Rifabutin—Asthenia—Vincristine—colon cancer	0.000958	0.00279	CcSEcCtD
Rifabutin—Leukopenia—Capecitabine—colon cancer	0.000954	0.00278	CcSEcCtD
Rifabutin—Agranulocytosis—Methotrexate—colon cancer	0.000948	0.00276	CcSEcCtD
Rifabutin—HSP90AA1—EPH-Ephrin signaling—SRC—colon cancer	0.000934	0.00283	CbGpPWpGaD
Rifabutin—Asthenia—Irinotecan—colon cancer	0.000933	0.00272	CcSEcCtD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—CTNNB1—colon cancer	0.000931	0.00283	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling events mediated by VEGFR1 and VEGFR2—PIK3CA—colon cancer	0.00092	0.00279	CbGpPWpGaD
Rifabutin—Hypersensitivity—Fluorouracil—colon cancer	0.000917	0.00267	CcSEcCtD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—NRAS—colon cancer	0.000914	0.00277	CbGpPWpGaD
Rifabutin—Diarrhoea—Vincristine—colon cancer	0.000913	0.00266	CcSEcCtD
Rifabutin—Hepatitis—Methotrexate—colon cancer	0.000912	0.00265	CcSEcCtD
Rifabutin—HSP90AA1—EPH-Ephrin signaling—VEGFA—colon cancer	0.000909	0.00276	CbGpPWpGaD
Rifabutin—Myalgia—Capecitabine—colon cancer	0.000908	0.00264	CcSEcCtD
Rifabutin—Arthralgia—Capecitabine—colon cancer	0.000908	0.00264	CcSEcCtD
Rifabutin—Chest pain—Capecitabine—colon cancer	0.000908	0.00264	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000901	0.00262	CcSEcCtD
Rifabutin—HSP90AA1—Developmental Biology—HNF4A—colon cancer	0.000896	0.00272	CbGpPWpGaD
Rifabutin—Diarrhoea—Irinotecan—colon cancer	0.000889	0.00259	CcSEcCtD
Rifabutin—Pruritus—Fluorouracil—colon cancer	0.000881	0.00257	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by VEGF—CTNNB1—colon cancer	0.000879	0.00267	CbGpPWpGaD
Rifabutin—Confusional state—Capecitabine—colon cancer	0.000877	0.00255	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—BCL10—colon cancer	0.000865	0.00263	CbGpPWpGaD
Rifabutin—Shock—Capecitabine—colon cancer	0.000856	0.00249	CcSEcCtD
Rifabutin—Eye disorder—Methotrexate—colon cancer	0.000852	0.00248	CcSEcCtD
Rifabutin—Diarrhoea—Fluorouracil—colon cancer	0.000852	0.00248	CcSEcCtD
Rifabutin—Thrombocytopenia—Capecitabine—colon cancer	0.000852	0.00248	CcSEcCtD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—TGFB1—colon cancer	0.000849	0.00258	CbGpPWpGaD
Rifabutin—Vomiting—Vincristine—colon cancer	0.000849	0.00247	CcSEcCtD
Rifabutin—Skin disorder—Capecitabine—colon cancer	0.000845	0.00246	CcSEcCtD
Rifabutin—HSP90AA1—Metabolism—CHST5—colon cancer	0.000842	0.00255	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—ODC1—colon cancer	0.000842	0.00255	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—SRC—colon cancer	0.000842	0.00255	CbGpPWpGaD
Rifabutin—Rash—Vincristine—colon cancer	0.000842	0.00245	CcSEcCtD
Rifabutin—Dermatitis—Vincristine—colon cancer	0.000841	0.00245	CcSEcCtD
Rifabutin—Headache—Vincristine—colon cancer	0.000836	0.00244	CcSEcCtD
Rifabutin—Anorexia—Capecitabine—colon cancer	0.000829	0.00242	CcSEcCtD
Rifabutin—HSP90AA1—G2/M Transition—EP300—colon cancer	0.000829	0.00251	CbGpPWpGaD
Rifabutin—Vomiting—Irinotecan—colon cancer	0.000826	0.00241	CcSEcCtD
Rifabutin—Immune system disorder—Methotrexate—colon cancer	0.000823	0.0024	CcSEcCtD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—VEGFA—colon cancer	0.00082	0.00249	CbGpPWpGaD
Rifabutin—Rash—Irinotecan—colon cancer	0.00082	0.00239	CcSEcCtD
Rifabutin—Dermatitis—Irinotecan—colon cancer	0.000819	0.00238	CcSEcCtD
Rifabutin—HSP90AA1—Mitotic G2-G2/M phases—EP300—colon cancer	0.000817	0.00248	CbGpPWpGaD
Rifabutin—Headache—Irinotecan—colon cancer	0.000814	0.00237	CcSEcCtD
Rifabutin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000811	0.00246	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—NRAS—colon cancer	0.00081	0.00246	CbGpPWpGaD
Rifabutin—HSP90AA1—Fcgamma receptor (FCGR) dependent phagocytosis—PIK3CA—colon cancer	0.0008	0.00243	CbGpPWpGaD
Rifabutin—HSP90AA1—Integrins in angiogenesis—AKT1—colon cancer	0.000799	0.00242	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by VEGF—SRC—colon cancer	0.000795	0.00241	CbGpPWpGaD
Rifabutin—Nausea—Vincristine—colon cancer	0.000793	0.00231	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000793	0.00231	CcSEcCtD
Rifabutin—Vomiting—Fluorouracil—colon cancer	0.000792	0.00231	CcSEcCtD
Rifabutin—HSP90AA1—Validated targets of C-MYC transcriptional activation—TP53—colon cancer	0.00079	0.0024	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	0.000788	0.00239	CbGpPWpGaD
Rifabutin—Insomnia—Capecitabine—colon cancer	0.000787	0.00229	CcSEcCtD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—KRAS—colon cancer	0.000786	0.00239	CbGpPWpGaD
Rifabutin—Rash—Fluorouracil—colon cancer	0.000785	0.00229	CcSEcCtD
Rifabutin—Dermatitis—Fluorouracil—colon cancer	0.000784	0.00228	CcSEcCtD
Rifabutin—Paraesthesia—Capecitabine—colon cancer	0.000781	0.00228	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle—MLH1—colon cancer	0.00078	0.00237	CbGpPWpGaD
Rifabutin—Headache—Fluorouracil—colon cancer	0.00078	0.00227	CcSEcCtD
Rifabutin—Dysgeusia—Methotrexate—colon cancer	0.000777	0.00226	CcSEcCtD
Rifabutin—Dyspnoea—Capecitabine—colon cancer	0.000776	0.00226	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by VEGF—VEGFA—colon cancer	0.000774	0.00235	CbGpPWpGaD
Rifabutin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000772	0.00234	CbGpPWpGaD
Rifabutin—Nausea—Irinotecan—colon cancer	0.000772	0.00225	CcSEcCtD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—TP53—colon cancer	0.000766	0.00233	CbGpPWpGaD
Rifabutin—Dyspepsia—Capecitabine—colon cancer	0.000766	0.00223	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by VEGF—NRAS—colon cancer	0.000764	0.00232	CbGpPWpGaD
Rifabutin—Decreased appetite—Capecitabine—colon cancer	0.000756	0.0022	CcSEcCtD
Rifabutin—HSP90AA1—Regulation of Telomerase—AKT1—colon cancer	0.000752	0.00228	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—colon cancer	0.000752	0.00228	CbGpPWpGaD
Rifabutin—Gastrointestinal disorder—Capecitabine—colon cancer	0.000751	0.00219	CcSEcCtD
Rifabutin—HSP90AA1—Signaling Pathways—DLC1—colon cancer	0.000749	0.00227	CbGpPWpGaD
Rifabutin—Pain—Capecitabine—colon cancer	0.000744	0.00217	CcSEcCtD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—colon cancer	0.000743	0.00226	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—BUB1B—colon cancer	0.000742	0.00225	CbGpPWpGaD
Rifabutin—Nausea—Fluorouracil—colon cancer	0.000739	0.00215	CcSEcCtD
Rifabutin—Anaemia—Methotrexate—colon cancer	0.000733	0.00214	CcSEcCtD
Rifabutin—HSP90AA1—Disease—AXIN2—colon cancer	0.000722	0.00219	CbGpPWpGaD
Rifabutin—Feeling abnormal—Capecitabine—colon cancer	0.000717	0.00209	CcSEcCtD
Rifabutin—Gastrointestinal pain—Capecitabine—colon cancer	0.000711	0.00207	CcSEcCtD
Rifabutin—Leukopenia—Methotrexate—colon cancer	0.00071	0.00207	CcSEcCtD
Rifabutin—HSP90B1—Immune System—CD8A—colon cancer	0.000707	0.00215	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—LGR5—colon cancer	0.000704	0.00214	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—KRAS—colon cancer	0.000697	0.00211	CbGpPWpGaD
Rifabutin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000696	0.00211	CbGpPWpGaD
Rifabutin—Abdominal pain—Capecitabine—colon cancer	0.000688	0.002	CcSEcCtD
Rifabutin—Body temperature increased—Capecitabine—colon cancer	0.000688	0.002	CcSEcCtD
Rifabutin—Convulsion—Methotrexate—colon cancer	0.000688	0.002	CcSEcCtD
Rifabutin—Myalgia—Methotrexate—colon cancer	0.000676	0.00197	CcSEcCtD
Rifabutin—Chest pain—Methotrexate—colon cancer	0.000676	0.00197	CcSEcCtD
Rifabutin—Arthralgia—Methotrexate—colon cancer	0.000676	0.00197	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000671	0.00195	CcSEcCtD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—HRAS—colon cancer	0.000668	0.00203	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—BUB1B—colon cancer	0.000663	0.00201	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by VEGF—KRAS—colon cancer	0.000658	0.002	CbGpPWpGaD
Rifabutin—HSP90AA1—EPH-Ephrin signaling—HRAS—colon cancer	0.000657	0.00199	CbGpPWpGaD
Rifabutin—Confusional state—Methotrexate—colon cancer	0.000653	0.0019	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by ERBB2—CDKN1A—colon cancer	0.00065	0.00197	CbGpPWpGaD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—AKT1—colon cancer	0.000647	0.00196	CbGpPWpGaD
Rifabutin—Hypersensitivity—Capecitabine—colon cancer	0.000641	0.00187	CcSEcCtD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—PIK3CA—colon cancer	0.00064	0.00194	CbGpPWpGaD
Rifabutin—Thrombocytopenia—Methotrexate—colon cancer	0.000634	0.00185	CcSEcCtD
Rifabutin—Skin disorder—Methotrexate—colon cancer	0.000629	0.00183	CcSEcCtD
Rifabutin—Asthenia—Capecitabine—colon cancer	0.000624	0.00182	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—CTNNB1—colon cancer	0.00062	0.00188	CbGpPWpGaD
Rifabutin—Anorexia—Methotrexate—colon cancer	0.000617	0.0018	CcSEcCtD
Rifabutin—Pruritus—Capecitabine—colon cancer	0.000616	0.00179	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—CDKN1A—colon cancer	0.000605	0.00184	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—BCL2L1—colon cancer	0.000605	0.00184	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by VEGF—PIK3CA—colon cancer	0.000604	0.00183	CbGpPWpGaD
Rifabutin—HSP90AA1—Influenza Infection—TGFB1—colon cancer	0.000603	0.00183	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—SRC—colon cancer	0.000601	0.00182	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—CDKN1A—colon cancer	0.000597	0.00181	CbGpPWpGaD
Rifabutin—Diarrhoea—Capecitabine—colon cancer	0.000595	0.00173	CcSEcCtD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—HRAS—colon cancer	0.000592	0.0018	CbGpPWpGaD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—AKT1—colon cancer	0.00059	0.00179	CbGpPWpGaD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—AKT1—colon cancer	0.00059	0.00179	CbGpPWpGaD
Rifabutin—Musculoskeletal discomfort—Methotrexate—colon cancer	0.00059	0.00172	CcSEcCtD
Rifabutin—HSP90AA1—NRF2 pathway—TGFB1—colon cancer	0.000587	0.00178	CbGpPWpGaD
Rifabutin—Insomnia—Methotrexate—colon cancer	0.000586	0.00171	CcSEcCtD
Rifabutin—Paraesthesia—Methotrexate—colon cancer	0.000582	0.00169	CcSEcCtD
Rifabutin—HSP90B1—Immune System—FGFR3—colon cancer	0.000579	0.00176	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—NRAS—colon cancer	0.000578	0.00175	CbGpPWpGaD
Rifabutin—Dyspnoea—Methotrexate—colon cancer	0.000577	0.00168	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—EP300—colon cancer	0.000576	0.00175	CbGpPWpGaD
Rifabutin—Dyspepsia—Methotrexate—colon cancer	0.00057	0.00166	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—TYMS—colon cancer	0.000569	0.00173	CbGpPWpGaD
Rifabutin—Decreased appetite—Methotrexate—colon cancer	0.000563	0.00164	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—SRC—colon cancer	0.00056	0.0017	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by VEGF—HRAS—colon cancer	0.000559	0.0017	CbGpPWpGaD
Rifabutin—Gastrointestinal disorder—Methotrexate—colon cancer	0.000559	0.00163	CcSEcCtD
Rifabutin—Pain—Methotrexate—colon cancer	0.000554	0.00161	CcSEcCtD
Rifabutin—Vomiting—Capecitabine—colon cancer	0.000553	0.00161	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—SRC—colon cancer	0.000553	0.00168	CbGpPWpGaD
Rifabutin—Rash—Capecitabine—colon cancer	0.000549	0.0016	CcSEcCtD
Rifabutin—Dermatitis—Capecitabine—colon cancer	0.000548	0.0016	CcSEcCtD
Rifabutin—Headache—Capecitabine—colon cancer	0.000545	0.00159	CcSEcCtD
Rifabutin—HSP90B1—Metabolism of proteins—CTNNB1—colon cancer	0.000541	0.00164	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—NRAS—colon cancer	0.000539	0.00163	CbGpPWpGaD
Rifabutin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000537	0.00163	CbGpPWpGaD
Rifabutin—Feeling abnormal—Methotrexate—colon cancer	0.000534	0.00155	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—NRAS—colon cancer	0.000532	0.00161	CbGpPWpGaD
Rifabutin—Gastrointestinal pain—Methotrexate—colon cancer	0.00053	0.00154	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by ERBB2—EGFR—colon cancer	0.000527	0.0016	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—AKT1—colon cancer	0.000523	0.00159	CbGpPWpGaD
Rifabutin—Nausea—Capecitabine—colon cancer	0.000517	0.0015	CcSEcCtD
Rifabutin—Body temperature increased—Methotrexate—colon cancer	0.000512	0.00149	CcSEcCtD
Rifabutin—Abdominal pain—Methotrexate—colon cancer	0.000512	0.00149	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle—TYMS—colon cancer	0.000509	0.00154	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—AXIN2—colon cancer	0.000506	0.00153	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—BCL10—colon cancer	0.000504	0.00153	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—KRAS—colon cancer	0.000498	0.00151	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by VEGF—AKT1—colon cancer	0.000494	0.0015	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—EGFR—colon cancer	0.000491	0.00149	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—CDH1—colon cancer	0.000489	0.00148	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—EGFR—colon cancer	0.000484	0.00147	CbGpPWpGaD
Rifabutin—Hypersensitivity—Methotrexate—colon cancer	0.000477	0.00139	CcSEcCtD
Rifabutin—Asthenia—Methotrexate—colon cancer	0.000465	0.00135	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—KRAS—colon cancer	0.000464	0.00141	CbGpPWpGaD
Rifabutin—Pruritus—Methotrexate—colon cancer	0.000458	0.00133	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—KRAS—colon cancer	0.000458	0.00139	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—PIK3CA—colon cancer	0.000457	0.00139	CbGpPWpGaD
Rifabutin—Diarrhoea—Methotrexate—colon cancer	0.000443	0.00129	CcSEcCtD
Rifabutin—HSP90AA1—Cellular responses to stress—CDKN1A—colon cancer	0.000442	0.00134	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—colon cancer	0.00043	0.0013	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—PIK3CA—colon cancer	0.000426	0.00129	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—HRAS—colon cancer	0.000423	0.00128	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—PIK3CA—colon cancer	0.00042	0.00128	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—EP300—colon cancer	0.00042	0.00128	CbGpPWpGaD
Rifabutin—Vomiting—Methotrexate—colon cancer	0.000412	0.0012	CcSEcCtD
Rifabutin—Rash—Methotrexate—colon cancer	0.000408	0.00119	CcSEcCtD
Rifabutin—Dermatitis—Methotrexate—colon cancer	0.000408	0.00119	CcSEcCtD
Rifabutin—Headache—Methotrexate—colon cancer	0.000406	0.00118	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—BCL2L1—colon cancer	0.000406	0.00123	CbGpPWpGaD
Rifabutin—CYP1A2—Arachidonic acid metabolism—PTGS2—colon cancer	0.000402	0.00122	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—VEGFA—colon cancer	0.000398	0.00121	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—HRAS—colon cancer	0.000394	0.0012	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—PPARG—colon cancer	0.000389	0.00118	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—HRAS—colon cancer	0.000389	0.00118	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—FGFR3—colon cancer	0.000388	0.00118	CbGpPWpGaD
Rifabutin—Nausea—Methotrexate—colon cancer	0.000385	0.00112	CcSEcCtD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	0.000376	0.00114	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—AKT1—colon cancer	0.000374	0.00113	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—CTNNB1—colon cancer	0.000361	0.00109	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—colon cancer	0.000358	0.00109	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	0.000358	0.00109	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—CDKN1A—colon cancer	0.000353	0.00107	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—AKT1—colon cancer	0.000348	0.00106	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—SRC—colon cancer	0.000348	0.00106	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	0.000348	0.00106	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—SRC—colon cancer	0.000347	0.00105	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—AKT1—colon cancer	0.000344	0.00104	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	0.000339	0.00103	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—VEGFA—colon cancer	0.000338	0.00103	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—EP300—colon cancer	0.000335	0.00102	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—colon cancer	0.000335	0.00102	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—NRAS—colon cancer	0.000334	0.00101	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—SRC—colon cancer	0.000326	0.00099	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—NRAS—colon cancer	0.000314	0.000952	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—colon cancer	0.000312	0.000946	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	0.000311	0.000943	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—colon cancer	0.000305	0.000925	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	0.000305	0.000925	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—EGFR—colon cancer	0.000304	0.000923	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—TP53—colon cancer	0.000301	0.000913	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CA7—colon cancer	0.000292	0.000887	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—colon cancer	0.000288	0.000874	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—KRAS—colon cancer	0.000287	0.000872	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—CCND1—colon cancer	0.000286	0.000869	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—EGFR—colon cancer	0.000286	0.000867	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—CDKN1A—colon cancer	0.000277	0.000841	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CD8A—colon cancer	0.000276	0.000838	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—CTNNB1—colon cancer	0.000274	0.000831	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—KRAS—colon cancer	0.00027	0.000819	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—EP300—colon cancer	0.000264	0.0008	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—CCND1—colon cancer	0.000256	0.000777	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—EP300—colon cancer	0.000255	0.000772	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—PIK3CA—colon cancer	0.000248	0.000753	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—CDKN1A—colon cancer	0.000248	0.000752	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—SRC—colon cancer	0.000248	0.000751	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—colon cancer	0.000245	0.000743	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—HRAS—colon cancer	0.000244	0.000741	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—CTNNB1—colon cancer	0.000242	0.000734	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—VEGFA—colon cancer	0.000241	0.000732	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—NRAS—colon cancer	0.000238	0.000723	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—CDKN1A—colon cancer	0.000236	0.000717	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—BCL2L1—colon cancer	0.000236	0.000717	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—EP300—colon cancer	0.000236	0.000715	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—MYC—colon cancer	0.00023	0.000697	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—HRAS—colon cancer	0.00023	0.000697	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—FGFR3—colon cancer	0.000226	0.000685	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CA7—colon cancer	0.000226	0.000684	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—EP300—colon cancer	0.000225	0.000682	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—ABCB1—colon cancer	0.000222	0.000675	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—TGFB1—colon cancer	0.000221	0.000671	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—SRC—colon cancer	0.000219	0.000663	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—TYMS—colon cancer	0.000218	0.000663	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—EGFR—colon cancer	0.000217	0.000658	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—NRAS—colon cancer	0.00021	0.000638	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—FGFR3—colon cancer	0.000209	0.000633	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—MYC—colon cancer	0.000205	0.000623	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—KRAS—colon cancer	0.000205	0.000622	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—AKT1—colon cancer	0.000203	0.000615	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—EGFR—colon cancer	0.000192	0.000581	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—APC—colon cancer	0.000191	0.000581	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CDH1—colon cancer	0.000191	0.000579	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—KRAS—colon cancer	0.000181	0.000549	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—BRAF—colon cancer	0.00018	0.000546	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ODC1—colon cancer	0.000177	0.000537	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CHST5—colon cancer	0.000177	0.000537	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—HRAS—colon cancer	0.000174	0.000529	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—TP53—colon cancer	0.000169	0.000512	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—PIK3CA—colon cancer	0.000166	0.000505	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PPARG—colon cancer	0.000155	0.00047	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—HRAS—colon cancer	0.000154	0.000467	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—AKT1—colon cancer	0.000154	0.000467	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—FGFR3—colon cancer	0.000146	0.000443	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PTGS2—colon cancer	0.000145	0.000441	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CTNNB1—colon cancer	0.000141	0.000427	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CDKN1A—colon cancer	0.000138	0.000418	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ODC1—colon cancer	0.000137	0.000415	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CHST5—colon cancer	0.000137	0.000415	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—AKT1—colon cancer	0.000136	0.000412	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—APC—colon cancer	0.000134	0.000407	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—EP300—colon cancer	0.000131	0.000397	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CTNNB1—colon cancer	0.00013	0.000395	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—SRC—colon cancer	0.000127	0.000386	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CDKN1A—colon cancer	0.000127	0.000386	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—BRAF—colon cancer	0.000126	0.000382	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—NRAS—colon cancer	0.000123	0.000372	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PTGS2—colon cancer	0.000122	0.000369	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—EP300—colon cancer	0.000121	0.000367	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—SRC—colon cancer	0.000118	0.000357	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—NRAS—colon cancer	0.000113	0.000343	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—EGFR—colon cancer	0.000112	0.000339	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—KRAS—colon cancer	0.000105	0.00032	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MYC—colon cancer	0.000105	0.00032	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—TGFB1—colon cancer	0.000105	0.000319	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—EGFR—colon cancer	0.000103	0.000313	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—EP300—colon cancer	0.000101	0.000307	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—KRAS—colon cancer	9.74e-05	0.000295	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PIK3CA—colon cancer	9.69e-05	0.000294	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CASP3—colon cancer	9.45e-05	0.000287	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCND1—colon cancer	9.2e-05	0.000279	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CTNNB1—colon cancer	9.11e-05	0.000276	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—HRAS—colon cancer	8.96e-05	0.000272	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PIK3CA—colon cancer	8.94e-05	0.000271	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CDKN1A—colon cancer	8.9e-05	0.00027	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—EP300—colon cancer	8.47e-05	0.000257	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—HRAS—colon cancer	8.28e-05	0.000251	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SRC—colon cancer	8.23e-05	0.00025	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—VEGFA—colon cancer	8.02e-05	0.000243	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NRAS—colon cancer	7.92e-05	0.00024	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—AKT1—colon cancer	7.91e-05	0.00024	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PIK3CA—colon cancer	7.49e-05	0.000227	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MYC—colon cancer	7.38e-05	0.000224	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TGFB1—colon cancer	7.36e-05	0.000223	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	7.31e-05	0.000222	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—AKT1—colon cancer	7.31e-05	0.000222	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—EGFR—colon cancer	7.22e-05	0.000219	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—KRAS—colon cancer	6.82e-05	0.000207	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PIK3CA—colon cancer	6.26e-05	0.00019	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—AKT1—colon cancer	6.12e-05	0.000186	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TP53—colon cancer	6.06e-05	0.000184	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—HRAS—colon cancer	5.79e-05	0.000176	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	5.75e-05	0.000174	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—AKT1—colon cancer	5.12e-05	0.000155	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.78e-05	0.000145	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ABCB1—colon cancer	4.68e-05	0.000142	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—TYMS—colon cancer	4.6e-05	0.000139	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ABCB1—colon cancer	3.61e-05	0.00011	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—TYMS—colon cancer	3.55e-05	0.000108	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.54e-05	0.000107	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PPARG—colon cancer	3.26e-05	9.88e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PTGS2—colon cancer	2.56e-05	7.77e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PPARG—colon cancer	2.51e-05	7.62e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—EP300—colon cancer	2.13e-05	6.46e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PTGS2—colon cancer	1.98e-05	6e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—EP300—colon cancer	1.64e-05	4.99e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIK3CA—colon cancer	1.58e-05	4.78e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—AKT1—colon cancer	1.29e-05	3.91e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIK3CA—colon cancer	1.22e-05	3.69e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—AKT1—colon cancer	9.93e-06	3.01e-05	CbGpPWpGaD
